Ace Inhibitor

Discontinuation of renin-angiotensin system inhibitor therapy before major noncardiac surgery did not appear to affect postoperative outcomes vs. treatment continuation, a speaker reported.

In adults with hypertension and at least one CHD risk factor followed for up to 23 years, three antihypertensive medications did not differ in CVD mortality, according to long-term results of the ALLHAT trial.

During the early days of the COVID-19 pandemic when most people were hunkering down at home, Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP, kept going to her clinic in-person.

Testing the effectiveness of an innovative, clinic-level educational intervention to improve management of people with type 2 diabetes and CVD.

Adults with type 2 diabetes, chronic kidney disease or both conditions have high rates of hospital admissions and ED visits due in part to a low uptake of medications and a lack of engagement with routine assessments, researchers reported.

NEW ORLEANS — Implementing a coordinated care intervention in U.S. cardiology clinics led to a fourfold increase in the prescription of three groups of guideline-recommended therapies in adults with type 2 diabetes and atherosclerotic CVD.

NEW ORLEANS — Implementing a coordinated care intervention in U.S. cardiology clinics led to a fourfold increase in the prescription of three groups of guideline-recommended therapies in adults with type 2 diabetes and atherosclerotic CVD.

Data from a meta-analysis show that a 20% improvement in CV medication adherence could reduce risk for any CV event by 8% and risk for all-cause mortality by 12% among patients with CAD, researchers reported.

Polypill with aspirin, atorvastatin and ramipril vs. usual care for secondary prevention in patients with MI.

In older adults, a polypill containing aspirin, an ACE inhibitor and a statin within 6 months after myocardial infarction lowered the risk for major adverse CV events compared with usual care, according to results of the SECURE trial.